Defaulting from tuberculosis treatment in the Netherlands: rates risk factors and trend in the period 1993-1997

被引:24
作者
Borgdorff, MW
Veen, J
Kalisvaart, NA
Broekmans, JF
Nagelkerke, NJD
机构
[1] Royal Netherlands TB Assoc, NL-2501 CC The Hague, Netherlands
[2] Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands
关键词
defaulting; risk factors; treatment interruption; tuberculosis;
D O I
10.1034/j.1399-3003.2000.16b05.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of this study was to assess the rate of defaulting from treatment among tuberculosis patients diagnosed in the Netherlands in the period 1993-1997, whether risk groups for defaulting can be identified at the start of treatment and the trend of defaulting over time. The Netherlands Tuberculosis Register provided data on all patients diagnosed in the Netherlands during the period 1993-1997, Defaulting probabilities were determined using Kaplan-Meier survival analysis and risk factors were identified with Cox's proportional hazard analysis, Of 7,529 patients with reported treatment outcome, 718 (10%) defaulted or left the country within 1 yr after starting treatment. Defaulting probabilities were 9% (95% confidence interval (CI) 8-10%) among 5,256 patients in low-risk groups, 17% (95% CI 14-19%) among 1,437 asylum seekers and 29% (95% CI 24-34%) among 836 patients in other high-risk groups (other recent immigrants, illegal immigrants, the homeless, prisoners and nationals from Eastern Europe), Defaulting probabilities decreased over time from 12% in 1993 to 7% in 1997, Risk groups for defaulting can be recognized at the start of treatment, The decreasing defaulting probabilities were probably due in part to shortening treatment from 9 to 6 months and improved follow-up of asylum seekers. However, additional measures are needed to reduce defaulting among the homeless, recent immigrants, illegal immigrants and prisoners.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 20 条
  • [11] INTERRELATIONS BETWEEN RELAPSES, DRUG REGIMENS AND COMPLIANCE WITH TREATMENT IN TUBERCULOSIS
    ORMEROD, LP
    PRESCOTT, RJ
    [J]. RESPIRATORY MEDICINE, 1991, 85 (03) : 239 - 242
  • [12] PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0
  • [13] TUBERCULOSIS-CONTROL IN EUROPE AND INTERNATIONAL MIGRATION
    RIEDER, HL
    ZELLWEGER, JP
    RAVIGLIONE, MC
    KEIZER, ST
    MIGLIORI, GB
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (08) : 1545 - 1553
  • [14] RIEDER HL, 1995, EUR RESP J S20, V8, P620
  • [15] *ROYAL NETH TUB AS, 1997, INDEX TUB 1996
  • [16] Styblo K., 1991, EPIDEMIOLOGY TUBERCU, V24
  • [17] van Loenhout-Rooyackers J H, 1996, Ned Tijdschr Geneeskd, V140, P2181
  • [18] Standardized tuberculosis treatment outcome monitoring in Europe
    Veen, J
    Raviglione, M
    Rieder, HL
    Migliori, GB
    Graf, P
    Grzemska, M
    Zalesky, R
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (02) : 505 - 510
  • [19] THE EFFECT OF DIRECTLY OBSERVED THERAPY ON THE RATES OF DRUG-RESISTANCE AND RELAPSE IN TUBERCULOSIS
    WEIS, SE
    SLOCUM, PC
    BLAIS, FX
    KING, B
    NUNN, M
    MATNEY, GB
    GOMEZ, E
    FORESMAN, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) : 1179 - 1184
  • [20] Zierski M, 1989, Pneumologie, V43, P691